Latest News

Title
06 Apr 2017 Patient Guide in Pancreatic Cancer Now Available Also in Polish
05 Apr 2017 EMA Publishes Framework and Action Plan for Closer Interaction with the Academic Community Bioethics, legal and economic issues
04 Apr 2017 NICE Terminates Appraisal for Alectinib in Previously Treated ALK-positive Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
03 Apr 2017 FDA Grants Regular Approval to Palbociclib as Initial Endocrine Based Therapy Breast cancer - Anticancer agents & Biologic therapy
31 Mar 2017 FDA Grants Regular Approval to Osimertinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
30 Mar 2017 EMA Recommends Granting a Marketing Authorisation Under Exceptional Circumstances for Dinutuximab beta Apeiron Central nervous system malignancies - Anticancer agents & Biologic therapy
30 Mar 2017 ELCC 2017 Media Alert: Latest News in Lung Cancer Lung and other thoracic tumours
Publications Sales Coordinator
29 Mar 2017 FDA Approves PARP Inhibitor Niraparib Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Mar 2017 EMA Adopts a New Indication for Pembrolizumab Haematologic malignancies - Cancer Immunology and Immunotherapy
26 Mar 2017 EMA Adopts a New Indication for Nivolumab Head and neck cancers - Cancer Immunology and Immunotherapy
24 Mar 2017 FDA Grants Accelerated Approval to Avelumab Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
16 Mar 2017 FDA Grants Accelerated Approval to Pembrolizumab for the Treatment of Classical Hodgkin Lymphoma Cancer Immunology and Immunotherapy